Reuters Market Eye - The BSE Sensex falls 0.77 percent, while the broader Nifty is lower 0.8 percent, after earlier marking their lowest level since April 16.
Asian shares fall to a fresh 9-1/2-month low as investors worry about China's economic and financial stability.
Shares of Ranbaxy Laboratories fall 3.6 percent after newspaper Business Standard reported the U.S. Food and Drug Administration had raised concerns about a plant in northern India, citing unidentified sources.
A Ranbaxy spokesman declined to comment whether it had received a query. The FDA was not immediately reachable for comment.
Indian shares are expected to remain volatile this week ahead of the expiry of June derivative contracts on Thursday.
Traders are also warily watching Indian stocks with heavy foreign ownership.
Housing Development Finance Corp Ltd , which has a 74 percent foreign ownership, is down 1.2 percent.
Foreign institutional investors have sold cash shares for nine straight sessions, totalling 77.60 billion rupees, as per exchange and regulatory data.
(Reporting by Abhishek Vishnoi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
